144 results
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that (i … the Representatives shall have received the opinion and negative assurance letter of Goodwin Procter LLP, counsel for the Company, dated as of such date
424B5
LRMR
Larimar Therapeutics Inc
14 Feb 24
Prospectus supplement for primary offering
5:08pm
an opinion or any other form of assurance with respect thereto. It is possible that we may identify items that require us to make adjustments … to continue as a going concern. There is no assurance that we will be successful in obtaining sufficient funding on acceptable terms, if at all. If we
424B5
q5bn5ncz9c0skgm
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
9ywhoi501nj
12 Feb 24
Results of Operations and Financial Condition
7:03am